| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.17e-04 | 188 | 63 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.40e-04 | 749 | 63 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 5.62e-04 | 120 | 63 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 6.34e-04 | 12 | 63 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 7.47e-04 | 13 | 63 | 2 | GO:0045028 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.86e-05 | 377 | 63 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.90e-05 | 378 | 63 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.94e-05 | 379 | 63 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 5.38e-05 | 133 | 63 | 5 | GO:0002062 | |
| GeneOntologyBiologicalProcess | artery development | 5.38e-05 | 133 | 63 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | THBS4 CD4 COMP CELSR2 HMCN1 NRCAM DSG3 GLI3 CD55 CCL21 IL7R IGDCC4 | 8.71e-05 | 1077 | 63 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.81e-04 | 92 | 63 | 4 | GO:0048844 | |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 ADAMTS12 THBS4 DST PSAP COMP HMCN1 ADAMTS9 SULF1 MMP19 ADAMTSL2 | 5.13e-06 | 656 | 65 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 ADAMTS12 THBS4 DST PSAP COMP HMCN1 ADAMTS9 SULF1 MMP19 ADAMTSL2 | 5.28e-06 | 658 | 65 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | membrane attack complex | 1.98e-04 | 7 | 65 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.30e-04 | 530 | 65 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | cell surface | SLC6A2 ADRA2B CD4 NRCAM PDGFRB ADAMTS9 SULF1 CD55 LRP4 CCL21 IL7R | 5.79e-04 | 1111 | 65 | 11 | GO:0009986 |
| Domain | TSP_1 | 6.12e-08 | 63 | 62 | 6 | PF00090 | |
| Domain | TSP1 | 7.41e-08 | 65 | 62 | 6 | SM00209 | |
| Domain | TSP1_rpt | 7.41e-08 | 65 | 62 | 6 | IPR000884 | |
| Domain | TSP1 | 7.41e-08 | 65 | 62 | 6 | PS50092 | |
| Domain | EGF_3 | 1.25e-05 | 235 | 62 | 7 | PS50026 | |
| Domain | Growth_fac_rcpt_ | 1.29e-05 | 156 | 62 | 6 | IPR009030 | |
| Domain | EGF-like_dom | 1.81e-05 | 249 | 62 | 7 | IPR000742 | |
| Domain | EGF_1 | 2.11e-05 | 255 | 62 | 7 | PS00022 | |
| Domain | EGF-like_CS | 2.45e-05 | 261 | 62 | 7 | IPR013032 | |
| Domain | EGF_2 | 2.70e-05 | 265 | 62 | 7 | PS01186 | |
| Domain | Thbs/COMP_coiled-coil | 3.25e-05 | 3 | 62 | 2 | IPR024665 | |
| Domain | COMP | 3.25e-05 | 3 | 62 | 2 | PF11598 | |
| Domain | EGF_CA | 5.26e-05 | 122 | 62 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.69e-05 | 124 | 62 | 5 | IPR001881 | |
| Domain | ADAM_spacer1 | 5.88e-05 | 23 | 62 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 5.88e-05 | 23 | 62 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 6.71e-05 | 24 | 62 | 3 | IPR013273 | |
| Domain | TSP_3 | 1.08e-04 | 5 | 62 | 2 | PF02412 | |
| Domain | TSP3 | 1.08e-04 | 5 | 62 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.08e-04 | 5 | 62 | 2 | PS51236 | |
| Domain | - | 1.08e-04 | 5 | 62 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.08e-04 | 5 | 62 | 2 | IPR008859 | |
| Domain | TSP_C | 1.08e-04 | 5 | 62 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.08e-04 | 5 | 62 | 2 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 1.08e-04 | 5 | 62 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 1.08e-04 | 5 | 62 | 2 | IPR028974 | |
| Domain | MACPF_CS | 1.61e-04 | 6 | 62 | 2 | IPR020863 | |
| Domain | EGF_CA | 1.91e-04 | 86 | 62 | 4 | PF07645 | |
| Domain | MACPF_2 | 2.25e-04 | 7 | 62 | 2 | PS51412 | |
| Domain | MACPF_1 | 2.25e-04 | 7 | 62 | 2 | PS00279 | |
| Domain | EGF_Ca-bd_CS | 3.03e-04 | 97 | 62 | 4 | IPR018097 | |
| Domain | LDLR_class-A_CS | 3.15e-04 | 40 | 62 | 3 | IPR023415 | |
| Domain | EGF_CA | 3.27e-04 | 99 | 62 | 4 | PS01187 | |
| Domain | CYSTEINE_SWITCH | 3.39e-04 | 41 | 62 | 3 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 3.91e-04 | 43 | 62 | 3 | IPR001818 | |
| Domain | Ldl_recept_a | 4.48e-04 | 45 | 62 | 3 | PF00057 | |
| Domain | MAC_perforin | 4.80e-04 | 10 | 62 | 2 | IPR001862 | |
| Domain | LDLRA_1 | 5.42e-04 | 48 | 62 | 3 | PS01209 | |
| Domain | LDLRA_2 | 5.76e-04 | 49 | 62 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 5.76e-04 | 49 | 62 | 3 | IPR002172 | |
| Domain | LDLa | 5.76e-04 | 49 | 62 | 3 | SM00192 | |
| Domain | MACPF | 5.85e-04 | 11 | 62 | 2 | PF01823 | |
| Domain | MACPF | 7.00e-04 | 12 | 62 | 2 | SM00457 | |
| Domain | MACPF | 7.00e-04 | 12 | 62 | 2 | IPR020864 | |
| Domain | EGF | 8.14e-04 | 126 | 62 | 4 | PF00008 | |
| Domain | IGc2 | 1.09e-03 | 235 | 62 | 5 | SM00408 | |
| Domain | Ig_sub2 | 1.09e-03 | 235 | 62 | 5 | IPR003598 | |
| Domain | EGF | 1.09e-03 | 235 | 62 | 5 | SM00181 | |
| Domain | CH | 1.31e-03 | 65 | 62 | 3 | SM00033 | |
| Domain | CH | 1.63e-03 | 70 | 62 | 3 | PF00307 | |
| Domain | - | 1.70e-03 | 71 | 62 | 3 | 1.10.418.10 | |
| Domain | PLAC | 1.79e-03 | 19 | 62 | 2 | PS50900 | |
| Domain | PLAC | 1.79e-03 | 19 | 62 | 2 | IPR010909 | |
| Domain | CH | 1.84e-03 | 73 | 62 | 3 | PS50021 | |
| Domain | CH-domain | 1.98e-03 | 75 | 62 | 3 | IPR001715 | |
| Domain | MetalloPept_cat_dom | 2.47e-03 | 81 | 62 | 3 | IPR024079 | |
| Domain | - | 2.47e-03 | 81 | 62 | 3 | 3.40.390.10 | |
| Domain | Actinin_actin-bd_CS | 2.62e-03 | 23 | 62 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 2.62e-03 | 23 | 62 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.62e-03 | 23 | 62 | 2 | PS00019 | |
| Domain | TRAF-like | 2.85e-03 | 24 | 62 | 2 | IPR008974 | |
| Domain | cEGF | 3.35e-03 | 26 | 62 | 2 | IPR026823 | |
| Domain | cEGF | 3.35e-03 | 26 | 62 | 2 | PF12662 | |
| Domain | Ig_I-set | 3.65e-03 | 190 | 62 | 4 | IPR013098 | |
| Domain | ig | 3.65e-03 | 190 | 62 | 4 | PF00047 | |
| Domain | Immunoglobulin | 3.65e-03 | 190 | 62 | 4 | IPR013151 | |
| Domain | I-set | 3.65e-03 | 190 | 62 | 4 | PF07679 | |
| Domain | - | 3.88e-03 | 95 | 62 | 3 | 2.60.120.200 | |
| Domain | ZINC_PROTEASE | 4.23e-03 | 98 | 62 | 3 | PS00142 | |
| Domain | ASX_HYDROXYL | 4.48e-03 | 100 | 62 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.27e-03 | 106 | 62 | 3 | IPR000152 | |
| Domain | - | 6.23e-03 | 663 | 62 | 7 | 2.60.40.10 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.59e-05 | 17 | 49 | 3 | MM15944 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 5.80e-05 | 22 | 49 | 3 | M39502 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.33e-04 | 330 | 49 | 7 | M18334 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.76e-04 | 463 | 49 | 8 | M507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 2.46e-04 | 7 | 49 | 2 | M47873 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 2.53e-04 | 89 | 49 | 4 | M39398 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 3.27e-04 | 8 | 49 | 2 | M27006 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 3.27e-04 | 8 | 49 | 2 | MM14656 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-04 | 39 | 49 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-04 | 39 | 49 | 3 | MM15165 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M22072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 4.20e-04 | 9 | 49 | 2 | M47881 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.70e-04 | 289 | 49 | 6 | MM15057 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.72e-04 | 300 | 49 | 6 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.93e-04 | 302 | 49 | 6 | M39719 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.14e-04 | 199 | 49 | 5 | M7253 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 6.64e-04 | 430 | 49 | 7 | MM15160 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 7.27e-04 | 314 | 49 | 6 | M600 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M48316 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 7.64e-04 | 12 | 49 | 2 | M10960 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.84e-04 | 326 | 49 | 6 | MM15917 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 9.01e-04 | 13 | 49 | 2 | M4732 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 9.87e-04 | 333 | 49 | 6 | MM14963 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.01e-03 | 57 | 49 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.06e-03 | 58 | 49 | 3 | M2049 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.08e-03 | 339 | 49 | 6 | M39736 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M7146 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.38e-03 | 16 | 49 | 2 | M6786 | |
| Pathway | WP_IRON_METABOLISM_DISORDERS | 1.56e-03 | 17 | 49 | 2 | M48053 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.69e-03 | 68 | 49 | 3 | M27303 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.76e-03 | 69 | 49 | 3 | M16894 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.16e-03 | 20 | 49 | 2 | M917 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.32e-03 | 76 | 49 | 3 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 2.68e-03 | 702 | 49 | 8 | M746 | |
| Pubmed | 3.28e-07 | 75 | 66 | 5 | 20637190 | ||
| Pubmed | 2.92e-06 | 15 | 66 | 3 | 20219786 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 30213581 | ||
| Pubmed | ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. | 3.55e-06 | 2 | 66 | 2 | 16611630 | |
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 3.55e-06 | 2 | 66 | 2 | 30464261 | |
| Pubmed | Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. | 3.55e-06 | 2 | 66 | 2 | 15879097 | |
| Pubmed | Ontogeny of stromal organizer cells during lymph node development. | 3.59e-06 | 16 | 66 | 3 | 20237296 | |
| Pubmed | 4.35e-06 | 17 | 66 | 3 | 19783990 | ||
| Pubmed | 6.90e-06 | 64 | 66 | 4 | 22261194 | ||
| Pubmed | Purinergic receptors expressed in human skeletal muscle fibres. | 1.06e-05 | 3 | 66 | 2 | 22052557 | |
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 1.06e-05 | 3 | 66 | 2 | 33910854 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 22640659 | ||
| Pubmed | Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients. | 1.06e-05 | 3 | 66 | 2 | 21757642 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 30988066 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 20539016 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 21209878 | ||
| Pubmed | YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells. | 1.12e-05 | 23 | 66 | 3 | 31980640 | |
| Pubmed | 1.23e-05 | 407 | 66 | 7 | 12693553 | ||
| Pubmed | CD4+CD25+CD127loFOXP3+ cell in food allergy: Does it predict anaphylaxis? | 2.12e-05 | 4 | 66 | 2 | 37169554 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 23282736 | ||
| Pubmed | Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway. | 2.12e-05 | 4 | 66 | 2 | 9500555 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 25688986 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 18485748 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 29077526 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 26333292 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 17591854 | ||
| Pubmed | 3.11e-05 | 32 | 66 | 3 | 18842294 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 30622267 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 12045112 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 16982861 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 10551839 | ||
| Pubmed | Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. | 3.53e-05 | 5 | 66 | 2 | 19180477 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 19366992 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 18467703 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 11690642 | ||
| Pubmed | 3.86e-05 | 329 | 66 | 6 | 17474147 | ||
| Pubmed | 4.02e-05 | 200 | 66 | 5 | 18240029 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 21928285 | ||
| Pubmed | Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. | 5.29e-05 | 6 | 66 | 2 | 22832194 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 12732660 | ||
| Pubmed | A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. | 5.29e-05 | 6 | 66 | 2 | 10893231 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 20797713 | ||
| Pubmed | CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. | 7.40e-05 | 7 | 66 | 2 | 30552328 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 11238592 | ||
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 27512039 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 9.86e-05 | 8 | 66 | 2 | 24460873 | |
| Pubmed | Molecular organization and function of the complement system. | 9.86e-05 | 8 | 66 | 2 | 3052276 | |
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 9693030 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 16717113 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 18849341 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 18947875 | ||
| Pubmed | Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. | 1.27e-04 | 9 | 66 | 2 | 19674979 | |
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 16815646 | ||
| Pubmed | Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. | 1.27e-04 | 9 | 66 | 2 | 24670648 | |
| Pubmed | 1.27e-04 | 51 | 66 | 3 | 20351714 | ||
| Pubmed | 1.47e-04 | 1285 | 66 | 10 | 35914814 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 30738849 | ||
| Pubmed | Interleukin-2 critically regulates bone marrow erythropoiesis and prevents anemia development. | 1.58e-04 | 10 | 66 | 2 | 26404745 | |
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 23750244 | ||
| Pubmed | GATA-3 is required for early T lineage progenitor development. | 1.58e-04 | 10 | 66 | 2 | 19934022 | |
| Pubmed | The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells. | 1.58e-04 | 10 | 66 | 2 | 26214742 | |
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 11167130 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 1.64e-04 | 824 | 66 | 8 | 20237496 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 1.83e-04 | 1070 | 66 | 9 | 23533145 | |
| Pubmed | Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection. | 1.93e-04 | 11 | 66 | 2 | 21704012 | |
| Pubmed | Separation of splenic red and white pulp occurs before birth in a LTalphabeta-independent manner. | 1.93e-04 | 11 | 66 | 2 | 18403646 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 23000144 | ||
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 14691482 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 20208005 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 2.31e-04 | 12 | 66 | 2 | 25770910 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.33e-04 | 1105 | 66 | 9 | 35748872 | |
| Pubmed | CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | 2.67e-04 | 163 | 66 | 4 | 23333304 | |
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 20444755 | ||
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 32909945 | ||
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 32268095 | ||
| Pubmed | Lrp4 modulates extracellular integration of cell signaling pathways in development. | 3.18e-04 | 14 | 66 | 2 | 19116665 | |
| Pubmed | A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. | 3.18e-04 | 14 | 66 | 2 | 20049410 | |
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 19380791 | ||
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 7590978 | ||
| Pubmed | Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk. | 3.67e-04 | 15 | 66 | 2 | 20233754 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 3.67e-04 | 15 | 66 | 2 | 9832566 | |
| Pubmed | 3.67e-04 | 15 | 66 | 2 | 26439735 | ||
| Pubmed | 3.67e-04 | 15 | 66 | 2 | 20498205 | ||
| Pubmed | Common variants at CD40 and other loci confer risk of rheumatoid arthritis. | 3.67e-04 | 15 | 66 | 2 | 18794853 | |
| Pubmed | 3.81e-04 | 179 | 66 | 4 | 18577758 | ||
| Pubmed | 4.18e-04 | 16 | 66 | 2 | 20439292 | ||
| Pubmed | 4.18e-04 | 16 | 66 | 2 | 19110536 | ||
| Pubmed | 4.30e-04 | 513 | 66 | 6 | 25798074 | ||
| Pubmed | 4.41e-04 | 186 | 66 | 4 | 20673868 | ||
| Pubmed | 4.41e-04 | 186 | 66 | 4 | 20452482 | ||
| Pubmed | 4.74e-04 | 17 | 66 | 2 | 21512159 | ||
| Pubmed | An interspecific linkage map of mouse chromosome 15 positioned with respect to the centromere. | 4.74e-04 | 17 | 66 | 2 | 1354638 | |
| Pubmed | Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. | 4.74e-04 | 17 | 66 | 2 | 9175833 | |
| Pubmed | 4.74e-04 | 17 | 66 | 2 | 22573622 | ||
| Pubmed | 5.05e-04 | 529 | 66 | 6 | 14621295 | ||
| Pubmed | 5.32e-04 | 18 | 66 | 2 | 24066094 | ||
| Pubmed | Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors. | 5.32e-04 | 18 | 66 | 2 | 35358427 | |
| Pubmed | Lymphatic Endothelial Cells Control Initiation of Lymph Node Organogenesis. | 5.32e-04 | 18 | 66 | 2 | 28709801 | |
| Pubmed | Pericytes are required for blood-brain barrier integrity during embryogenesis. | 5.94e-04 | 19 | 66 | 2 | 20944625 | |
| Pubmed | Lymph sacs are not required for the initiation of lymph node formation. | 5.94e-04 | 19 | 66 | 2 | 19060331 | |
| Cytoband | 5p13 | 2.81e-04 | 17 | 67 | 2 | 5p13 | |
| GeneFamily | Purinergic receptors P2Y | 3.06e-04 | 10 | 48 | 2 | 213 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.69e-04 | 161 | 48 | 4 | 593 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.15e-03 | 19 | 48 | 2 | 50 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.96e-05 | 64 | 65 | 4 | M2572 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 2.00e-05 | 337 | 65 | 7 | M13206 | |
| Coexpression | NABA_MATRISOME | COL3A1 ADAMTS12 THBS4 COMP HMCN1 ADAMTS9 SULF1 CCL21 MMP19 TNFSF15 ADAMTSL2 | 3.44e-05 | 1008 | 65 | 11 | MM17056 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 3.46e-05 | 505 | 65 | 8 | M39167 | |
| Coexpression | NABA_MATRISOME | COL3A1 ADAMTS12 THBS4 COMP HMCN1 ADAMTS9 SULF1 CCL21 MMP19 TNFSF15 ADAMTSL2 | 4.04e-05 | 1026 | 65 | 11 | M5889 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | COL3A1 ADAMTS12 THBS4 HMCN1 PDGFRB SULF1 PEG3 STEAP3 MMP19 GASK1B | 5.93e-07 | 437 | 63 | 10 | GSM777046_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 3.77e-06 | 418 | 63 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | COL3A1 ADAMTS12 CDR2 PDGFRB ADAMTS9 SULF1 STEAP3 MMP19 GASK1B | 6.25e-06 | 445 | 63 | 9 | GSM777043_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.11e-05 | 361 | 63 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.18e-05 | 364 | 63 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.40e-05 | 373 | 63 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 1.44e-05 | 494 | 63 | 9 | JC_fibro_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL3A1 SLC6A2 PRR16 CELF4 HMCN1 PDGFRB ADAMTS9 SULF1 NBPF9 TNFSF15 GASK1B IL7R TG | 1.59e-05 | 1094 | 63 | 13 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL3A1 HMCN1 PDGFRB ADAMTS9 SULF1 GLI3 PEG3 CD55 GASK1B HEPH IGDCC4 | 1.59e-05 | 777 | 63 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL3A1 ADAMTS12 HMCN1 PDGFRB ADAMTS9 SULF1 GLI3 PEG3 CD55 GASK1B HEPH | 2.83e-05 | 827 | 63 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 3.32e-05 | 206 | 63 | 6 | JC_fibro_500_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.41e-05 | 207 | 63 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | COL3A1 ADAMTS12 HMCN1 PDGFRB ADAMTS9 SULF1 GLI3 PEG3 CD55 LRP4 GASK1B | 3.59e-05 | 849 | 63 | 11 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.15e-05 | 337 | 63 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.37e-05 | 354 | 63 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 1.03e-04 | 157 | 63 | 5 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL3A1 HMCN1 PDGFRB ADAMTS9 SULF1 GLI3 PEG3 CD55 GASK1B IGDCC4 | 1.06e-04 | 793 | 63 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | COL3A1 ADAMTS12 HMCN1 PDGFRB SULF1 GLI3 PEG3 CD55 GASK1B IGDCC4 | 1.11e-04 | 797 | 63 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 1.14e-04 | 372 | 63 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.23e-04 | 261 | 63 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 1.48e-04 | 388 | 63 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 1.48e-04 | 388 | 63 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | smooth muscle | 1.48e-04 | 90 | 63 | 4 | smooth muscle | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL3A1 ADAMTS12 HMCN1 PDGFRB SULF1 GLI3 PEG3 CD55 GASK1B HEPH | 1.56e-04 | 831 | 63 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | COL3A1 ADAMTS12 HMCN1 PDGFRB SULF1 GLI3 PEG3 CD55 MIDEAS GASK1B | 2.02e-04 | 858 | 63 | 10 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.63e-04 | 42 | 63 | 3 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 2.85e-04 | 432 | 63 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.93e-04 | 732 | 63 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 2.99e-04 | 734 | 63 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_200 | 3.02e-04 | 44 | 63 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_200 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.17e-04 | 311 | 63 | 6 | JC_iEC_2500_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.17e-04 | 311 | 63 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 3.17e-04 | 740 | 63 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.14e-04 | 327 | 63 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 4.16e-04 | 768 | 63 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 4.36e-04 | 773 | 63 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.68e-04 | 51 | 63 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.76e-04 | 122 | 63 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 4.78e-04 | 783 | 63 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 5.15e-04 | 791 | 63 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.54e-04 | 54 | 63 | 3 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_1000 | |
| CoexpressionAtlas | CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2 | 5.85e-04 | 55 | 63 | 3 | GSM404003_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 5.89e-04 | 806 | 63 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 6.57e-04 | 357 | 63 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 6.84e-04 | 58 | 63 | 3 | GSM403987_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 7.29e-04 | 240 | 63 | 5 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200 | 7.56e-04 | 138 | 63 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_500 | 7.56e-04 | 138 | 63 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 7.72e-04 | 837 | 63 | 9 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 8.63e-04 | 143 | 63 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 9.33e-04 | 146 | 63 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 9.72e-04 | 385 | 63 | 6 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | gallbladder | 9.81e-04 | 148 | 63 | 4 | gallbladder | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 1.01e-03 | 16 | 63 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | BM Top 100 - lymph nodes | 1.09e-03 | 68 | 63 | 3 | BM Top 100 - lymph nodes | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.11e-03 | 153 | 63 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.13e-03 | 69 | 63 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.14e-03 | 265 | 63 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | THBS4 PSAP CELSR2 PDGFRB ADAMTS9 SULF1 GLI3 LRP4 HEPH IGDCC4 | 1.17e-03 | 1075 | 63 | 10 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | BM Top 100 - tonsil | 1.18e-03 | 70 | 63 | 3 | BM Top 100 - tonsil | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.31e-03 | 408 | 63 | 6 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_200 | 1.31e-03 | 160 | 63 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.34e-03 | 161 | 63 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.37e-03 | 162 | 63 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_200 | 1.43e-03 | 164 | 63 | 4 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_100 | 1.43e-03 | 19 | 63 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 1.43e-03 | 19 | 63 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k3_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 1.43e-03 | 19 | 63 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.47e-03 | 165 | 63 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 1.50e-03 | 166 | 63 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | BM Top 100 - urethra | 1.56e-03 | 77 | 63 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.58e-03 | 747 | 63 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.64e-03 | 170 | 63 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_1000 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.69e-11 | 197 | 67 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.79e-10 | 191 | 67 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.00e-10 | 192 | 67 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-10 | 193 | 67 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.42e-10 | 194 | 67 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.88e-10 | 196 | 67 | 8 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.12e-10 | 197 | 67 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.12e-10 | 197 | 67 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.37e-10 | 198 | 67 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.37e-10 | 198 | 67 | 8 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.37e-10 | 198 | 67 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-09 | 175 | 67 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 9.59e-09 | 178 | 67 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-08 | 180 | 67 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-08 | 180 | 67 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-08 | 183 | 67 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-08 | 183 | 67 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-08 | 183 | 67 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.35e-08 | 187 | 67 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-08 | 191 | 67 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-08 | 191 | 67 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-08 | 191 | 67 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-08 | 191 | 67 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-08 | 192 | 67 | 7 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-08 | 192 | 67 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-08 | 192 | 67 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-08 | 192 | 67 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-08 | 192 | 67 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-08 | 193 | 67 | 7 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-08 | 193 | 67 | 7 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-08 | 193 | 67 | 7 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-08 | 194 | 67 | 7 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-08 | 194 | 67 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-08 | 194 | 67 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-08 | 194 | 67 | 7 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-08 | 195 | 67 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-08 | 195 | 67 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-08 | 195 | 67 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-08 | 195 | 67 | 7 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-08 | 197 | 67 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 367C|World / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-08 | 198 | 67 | 7 | ab3a178f392204e2d90eb5a3b5de7849986b1eaf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.00e-08 | 198 | 67 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.07e-08 | 199 | 67 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.07e-08 | 199 | 67 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.07e-08 | 199 | 67 | 7 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.07e-08 | 199 | 67 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-08 | 200 | 67 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-08 | 200 | 67 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.14e-08 | 200 | 67 | 7 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-08 | 200 | 67 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-08 | 200 | 67 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.14e-08 | 200 | 67 | 7 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.14e-08 | 200 | 67 | 7 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-08 | 200 | 67 | 7 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.14e-08 | 200 | 67 | 7 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-08 | 200 | 67 | 7 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.90e-08 | 132 | 67 | 6 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 150 | 67 | 6 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 150 | 67 | 6 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-07 | 159 | 67 | 6 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-07 | 159 | 67 | 6 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-07 | 176 | 67 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-07 | 176 | 67 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 180 | 67 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 180 | 67 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-07 | 181 | 67 | 6 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 181 | 67 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-07 | 181 | 67 | 6 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 181 | 67 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-07 | 182 | 67 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-07 | 184 | 67 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-07 | 185 | 67 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 3.61e-07 | 185 | 67 | 6 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-07 | 186 | 67 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-07 | 186 | 67 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.73e-07 | 186 | 67 | 6 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.97e-07 | 188 | 67 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-07 | 189 | 67 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-07 | 189 | 67 | 6 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-07 | 189 | 67 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-07 | 189 | 67 | 6 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-07 | 189 | 67 | 6 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.22e-07 | 190 | 67 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-07 | 191 | 67 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.35e-07 | 191 | 67 | 6 | b680e0c35f1004be36f9f0680ae3c62952e2b607 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-07 | 191 | 67 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.35e-07 | 191 | 67 | 6 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.35e-07 | 191 | 67 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-07 | 192 | 67 | 6 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-07 | 192 | 67 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-07 | 192 | 67 | 6 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-07 | 192 | 67 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.49e-07 | 192 | 67 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.63e-07 | 193 | 67 | 6 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-07 | 193 | 67 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-07 | 193 | 67 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-07 | 193 | 67 | 6 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.63e-07 | 193 | 67 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-07 | 193 | 67 | 6 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-07 | 193 | 67 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| Computational | Genes in the cancer module 58. | 1.12e-04 | 21 | 49 | 3 | MODULE_58 | |
| Computational | Complement. | 1.48e-04 | 23 | 49 | 3 | MODULE_130 | |
| Drug | 4-fluorophenol | 4.15e-06 | 38 | 65 | 4 | CID000009732 | |
| Drug | CHEMBL2115063 | 5.12e-06 | 40 | 65 | 4 | CID009876936 | |
| Disease | Disproportionate short stature | 2.13e-05 | 77 | 62 | 4 | C0878659 | |
| Disease | Complement deficiency disease | 4.61e-05 | 33 | 62 | 3 | C0272242 | |
| Disease | Polysyndactyly | 9.06e-05 | 7 | 62 | 2 | C0265553 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 1.93e-04 | 10 | 62 | 2 | EFO_0008321 | |
| Disease | Liver Cirrhosis, Experimental | 2.09e-04 | 774 | 62 | 8 | C0023893 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.83e-04 | 12 | 62 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 2.83e-04 | 12 | 62 | 2 | EFO_0008141 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.99e-04 | 152 | 62 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | CD209 antigen measurement | 3.89e-04 | 14 | 62 | 2 | EFO_0008077 | |
| Disease | revision of total hip arthroplasty | 3.89e-04 | 14 | 62 | 2 | EFO_0020973 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 7.26e-04 | 19 | 62 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Heart valve disease | 1.37e-03 | 26 | 62 | 2 | C0018824 | |
| Disease | proteinuria (implicated_via_orthology) | 1.82e-03 | 30 | 62 | 2 | DOID:576 (implicated_via_orthology) | |
| Disease | coffee consumption | 2.07e-03 | 32 | 62 | 2 | EFO_0004330 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECSEIRQAGRPNKPD | 161 | O95150 | |
| PQKPAQGCRKDRGAS | 96 | O00585 | |
| QKQPCRGDNRDIGLE | 171 | Q8NAG6 | |
| QERRRECDNPAPQNG | 556 | P07357 | |
| ENVDKQTLRCNPRPG | 2281 | Q68DQ2 | |
| QANCPSLRPQRKGAD | 76 | Q5T5F5 | |
| RDNCRLVPNPGQEDA | 481 | P49747 | |
| PQPRGRPQCKLNQEA | 156 | P18089 | |
| QNGKAPRDPVTENCV | 261 | P08172 | |
| INRRCGNNPLIGRPN | 1241 | O60306 | |
| DNVPGQNGSRRPLVC | 151 | Q8N1D0 | |
| KPGVIGRQCDRCDNP | 1946 | Q9HCU4 | |
| PQQQREGPEGCNLFI | 386 | Q96J87 | |
| RGLCEQNLNPDANPR | 861 | Q9Y2H0 | |
| PEGEVRQGDQPVRCG | 391 | Q93084 | |
| GVQSAERLCNNPEPK | 561 | P58397 | |
| NGRKKSPPACRNQVE | 1116 | Q8TDY8 | |
| RRVVKPLCQDQPGGQ | 36 | A8MUP6 | |
| KPCREGEDNSKRNPI | 56 | P32926 | |
| KRPQQGAGNCSVARP | 171 | Q96G91 | |
| NCLNRQPVAPGALDG | 1256 | P10071 | |
| EDGTLICRANGNPKP | 376 | Q92823 | |
| GGIRDENGKPRCQNV | 2606 | Q03001 | |
| EARGKEKCPTLNGQP | 41 | Q9H478 | |
| CGKPQQLNRVVGGED | 41 | Q9GZN4 | |
| KSCPNPGEIRNGQID | 161 | P08174 | |
| ADAKPRPQQVRKQCG | 261 | A6NNH2 | |
| NPNACRASGRGLQPK | 451 | O75369 | |
| CQPSRVQAQGPGLKE | 1326 | O75369 | |
| RQPRCGLEDPFNQKT | 81 | Q99542 | |
| QGCYQEGQRIPPERE | 136 | O76083 | |
| QQRRKSVPGPGNRTC | 76 | Q86TH1 | |
| EKQRLGGDVQSPNCP | 336 | P16871 | |
| KRQKIPARENPCEGG | 871 | Q9GZU2 | |
| PARENPCEGGSKNRN | 876 | Q9GZU2 | |
| KRSRLCNQPLPANGG | 4551 | Q96RW7 | |
| PRNNQKPRDGNEEEC | 36 | P0DTF9 | |
| QLRQLCGGGKPQPRT | 316 | P51582 | |
| GFRPRKEDACVQNGL | 386 | Q6UWH4 | |
| AIRECNRPEPKNGGK | 611 | Q9P2N4 | |
| GNIQLTRGPPADCKN | 1771 | Q9Y2F5 | |
| TRECNNPAPQRGGKR | 586 | P13671 | |
| NPAPQRGGKRCEGEK | 591 | P13671 | |
| QGRRSPGKCDQEKPA | 141 | Q01850 | |
| REPPGQGCQAQEQKL | 1186 | Q5SYB0 | |
| PSVQCRSPRGKNIQG | 151 | P01730 | |
| NKRKRCLFGGQEPAP | 11 | Q6PJG2 | |
| PDGSRKNPARNCRDL | 1251 | P02461 | |
| EQTVRCRGRGMPQPN | 431 | P09619 | |
| NAPGVRLQLKAEGCP | 261 | Q86XP0 | |
| GVQCLLAPRDGDAQP | 41 | P23975 | |
| QERNRGQQPPKEGGE | 221 | O14545 | |
| TQCRKDVGRPQPGRE | 36 | P37802 | |
| RRGRKEGEENQNPPC | 846 | P0DPF3 | |
| CPQAGPRERVRFNEK | 196 | Q569H4 | |
| CKRGALDGNSPPQRQ | 206 | Q9BQS7 | |
| PCNPREKERIQNAGG | 171 | O75688 | |
| APNLQRCERLPDGRG | 91 | Q8NG41 | |
| RCEQDPGPGQTQRQE | 251 | Q92935 | |
| PQQQREGPEGCNLFI | 411 | Q9BZC1 | |
| NCPKFPNRDQRDKDG | 581 | P35443 | |
| QKPQAQKRGGRECRE | 1461 | Q14690 | |
| VVKNPGAQENGRCQE | 846 | O60296 | |
| GCRSQGPNREGKIQV | 321 | Q6ZTK2 | |
| AGPRDGNRQVPICGD | 156 | Q658P3 | |
| GNRQVPICGDQPEAK | 161 | Q658P3 | |
| PRNGEDQICPKCRGE | 46 | Q13077 | |
| RSKPQPKDNGDVCQD | 186 | P07602 | |
| ALQGERPRQSCPGEK | 86 | Q6P3V2 | |
| CNPRPKNLDVGNKDG | 841 | Q8IWU6 | |
| VRGGQPRCPTDCEKQ | 651 | P01266 | |
| HPQRQPAGKNRCGDN | 691 | O75096 |